-
Posted by
Two Blokes Jul 7 -
Filed in
Stock
-
2 views
NEWTOWN, Pa. , July 6, 2025 /PRNewswire/ -- Edelson Lechtzin LLP, a leading class action law firm, is investigating securities fraud claims on behalf of all investors of Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) who purchased stock pursuant to and/or traceable to Hims & Hers' statement announcing its long-term partnership with Novo Nordisk A/S on April 29, 2025.
